When we move our head, the whole visual world moves across our eyes. Yet we can still make out a bee buzzing by or a hawk flying overhead, thanks to unique cells in the eye called object motion…
Ocata Therapeutics Receives SBIR Grant from the NIH’s National Eye Institute to Develop Proprietary Photoreceptor Progenitor Cell Therapy for Retinitis Pigmentosa
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (NASDAQ:OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that it has been awarded a Small Business Innovation Research (SBIR) grant from the National Eye Institute (NEI), part of the National Institutes of Health (NIH), to fund Investigational New Drug (IND)-enabling preclinical development of Ocata’s proprietary photoreceptor progenitor product for the treatment of retinal degenerative diseases, such as r
Uncategorized
PubMed reflects linear increase in ophthalmology publications
The number of ophthalmology articles published and recorded in PubMed from 1998 to 2012 significantly increased in linear progression for both adult and pediatric ophthalmology topics, according to a study.“We found that there was a linear increase in publications over the study period in both pediatric and adult publications. However, the rate of increase was faster for adult publications (multiplication factor of 1.88) than for pediatric publications (multiplication factor of 1.66),” Michael Mimouni, MD, and colleagues said in the study.
BioLight Life Sciences Investments reports operational and financial results for Q2 2015
BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today reported operational and financial results for the second quarter ended June 30, 2015.
Blind Veterans UK calls for GPs to signpost blind and vision impaired ex-Service men and women to its free services
A national military charity is calling for help from GPs and surgery staff to ensure that blind and vision impaired ex-Service men and women are fully informed of the support available to them in…
Eleven Biotherapeutics Announces Promotions of Gary Sternberg, MD, MBA to Chief Business Officer and John McCabe, CPA to Senior Vice President, Finance
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Eleven announces promotions of Gary Sternberg, MD, MBA, to Chief Business Officer and John McCabe, CPA, to SVP, Finance. Mr. McCabe is also Principal Financial and Accounting Officer.